SCHEMBL4552227

SCHEMBL4552227

CNC(=O)c1cc(C(=O)Nc2ccc(C)c(-c3cc(C(=O)NCC(C)(C)C)on3)c2)cc(C(C)(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 19/20 0.44
BRAF P15056 19/20 0.44
HDAC3 O15379 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4410934 0.93 RAF1 (0.44) RAF1BRAFHDAC3HDAC6
SCHEMBL4410316 0.91 RAF1 (0.43) RAF1BRAFHDAC3HDAC6
SCHEMBL4408574 0.90 RAF1 (0.44) RAF1BRAFHDAC3HDAC6
SCHEMBL5593338 0.90 RAF1 (0.44) RAF1BRAFHDAC3HDAC6
SCHEMBL4411086 0.90 NR1H4 (0.46) RAF1BRAF
SCHEMBL4565782 0.90 BRAF (0.43) RAF1BRAF
SCHEMBL4565727 0.88 NR1H4 (0.48) RAF1BRAFHDAC6
SCHEMBL4413443 0.88 RAF1 (0.41) RAF1BRAFHDAC6
SCHEMBL4415077 0.88 RAF1 (0.52) RAF1BRAF
SCHEMBL4410213 0.88 RAF1 (0.42) RAF1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed
WO-2007075896-A2 HETEROCYCLIC CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-07-05 WO disclosed
WO-2007075896-A2 HETEROCYCLIC CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-07-05 WO disclosed